Education
About Us
Working with TipRanks
Follow Us
BioCorRx (BICX)
:BICX
Total Valuation
BioCorRx has a market cap or net worth of $4.61M. The enterprise value is $10.31M.
Market Cap$4.61M
Enterprise Value$10.31M
Share Statistics
BioCorRx has 16,099,432 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,099,432
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioCorRx’s return on equity (ROE) is 0.38 and return on invested capital (ROIC) is 87.81%.
Return on Equity (ROE)0.38
Return on Assets (ROA)-9.69
Return on Invested Capital (ROIC)87.81%
Return on Capital Employed (ROCE)0.63
Revenue Per Employee29.72K
Profits Per Employee-1.26M
Employee Count3
Asset Turnover0.23
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioCorRx is -1.73. BioCorRx’s PEG ratio is 0.07.
PE Ratio-1.73
PS Ratio153.35
PB Ratio-0.66
Price to Fair Value-0.66
Price to FCF-3.51
Price to Operating Cash Flow-3.51
PEG Ratio0.07
Income Statement
In the last 12 months, BioCorRx had revenue of 89.16K and earned -3.77M in profits. Earnings per share was -0.45.
Revenue89.16K
Gross Profit53.17K
Operating Income-3.79M
Pretax Income-3.77M
Net Income-3.77M
EBITDA-2.68M
Earnings Per Share (EPS)-0.45
Cash Flow
In the last 12 months, operating cash flow was -1.38M and capital expenditures 0.00, giving a free cash flow of -1.38M billion.
Operating Cash Flow-1.38M
Free Cash Flow-1.38M
Free Cash Flow per Share-0.09
Dividends & Yields
BioCorRx pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.46
52-Week Price Change-61.33%
50-Day Moving Average0.37
200-Day Moving Average0.38
Relative Strength Index (RSI)38.91
Average Volume (3m)2.12K
Important Dates
BioCorRx upcoming earnings date is May 20, 2025, TBA Not Confirmed.
Last Earnings DateNov 12, 2024
Next Earnings DateMay 20, 2025
Ex-Dividend Date―
Financial Position
BioCorRx as a current ratio of 0.03, with Debt / Equity ratio of -23.53%
Current Ratio0.03
Quick Ratio0.03
Debt to Market Cap0.26
Net Debt to EBITDA-0.65
Interest Coverage Ratio-4.27
Taxes
In the past 12 months, BioCorRx has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioCorRx EV to EBITDA ratio is -3.08, with an EV/FCF ratio of -4.45.
EV to Sales92.59
EV to EBITDA-3.08
EV to Free Cash Flow-4.45
EV to Operating Cash Flow-4.45
Balance Sheet
BioCorRx has $90.00 in cash and marketable securities with $100.00 in debt, giving a net cash position of $2.78M billion.
Cash & Marketable Securities$90.00
Total Debt$100.00
Net Cash$2.78M
Net Cash Per Share$0.17
Tangible Book Value Per Share-$1.19
Margins
Gross margin is -407.25%, with operating margin of -4248.31%, and net profit margin of -4224.89%.
Gross Margin-407.25%
Operating Margin-4248.31%
Pretax Margin-4228.90%
Net Profit Margin-4224.89%
EBITDA Margin-3010.23%
EBIT Margin-3234.48%
Analyst Forecast
The average price target for BioCorRx is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-91.40%
EPS Growth Forecast-8.98%